Sushma Devi

903 total citations
45 papers, 566 citations indexed

About

Sushma Devi is a scholar working on Physiology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Sushma Devi has authored 45 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 10 papers in Molecular Biology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Sushma Devi's work include Phytochemicals and Antioxidant Activities (8 papers), Natural Antidiabetic Agents Studies (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Sushma Devi is often cited by papers focused on Phytochemicals and Antioxidant Activities (8 papers), Natural Antidiabetic Agents Studies (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Sushma Devi collaborates with scholars based in India, Saudi Arabia and United States. Sushma Devi's co-authors include Randhir Singh, Aftab Alam, Sarita Azad, Ahmed I. Foudah, Mohammad Ayman Salkini, Mohammed H. Alqarni, Manish Kumar, Thakur Gurjeet Singh, Hasan S. Yusufoglu and Samir A. Ross and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Molecules.

In The Last Decade

Sushma Devi

42 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sushma Devi India 13 146 87 81 75 64 45 566
Alan Bruno Silva Vasconcelos Brazil 10 146 1.0× 89 1.0× 107 1.3× 62 0.8× 68 1.1× 28 520
Yuwei Liu China 13 211 1.4× 92 1.1× 109 1.3× 63 0.8× 79 1.2× 33 646
Munavvar Zubaid Abdul Sattar Malaysia 11 135 0.9× 96 1.1× 125 1.5× 67 0.9× 92 1.4× 16 543
Shital S. Panchal India 14 122 0.8× 89 1.0× 109 1.3× 48 0.6× 55 0.9× 34 536
Mohd Fahami Nur Azlina Malaysia 16 159 1.1× 128 1.5× 76 0.9× 74 1.0× 73 1.1× 62 750
Xiaojing Liu China 16 149 1.0× 55 0.6× 77 1.0× 82 1.1× 52 0.8× 40 538
Junko Yokota Japan 12 179 1.2× 78 0.9× 95 1.2× 52 0.7× 49 0.8× 31 554
Ali Attiq Malaysia 10 258 1.8× 74 0.9× 124 1.5× 59 0.8× 56 0.9× 22 746
Said Moshawih Malaysia 14 133 0.9× 54 0.6× 106 1.3× 52 0.7× 56 0.9× 39 550
Jessy Moore Canada 9 180 1.2× 99 1.1× 71 0.9× 41 0.5× 93 1.5× 18 463

Countries citing papers authored by Sushma Devi

Since Specialization
Citations

This map shows the geographic impact of Sushma Devi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sushma Devi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sushma Devi more than expected).

Fields of papers citing papers by Sushma Devi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sushma Devi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sushma Devi. The network helps show where Sushma Devi may publish in the future.

Co-authorship network of co-authors of Sushma Devi

This figure shows the co-authorship network connecting the top 25 collaborators of Sushma Devi. A scholar is included among the top collaborators of Sushma Devi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sushma Devi. Sushma Devi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaur, Manpreet, et al.. (2025). Therapeutic Potential of 3‐(4‐Chlorophenyl)‐4‐(2‐Hydroxyphenyl) 1,3‐Oxazetidin‐2‐One in STZ‐Induced Diabetic Neuropathic Pain in Rats. Fundamental and Clinical Pharmacology. 39(4). e70026–e70026. 1 indexed citations
2.
Devi, Sushma, Randhir Singh, Neeraj Mittal, & Thakur Gurjeet Singh. (2025). Role of Free Radicals in Pathology. Apple Academic Press eBooks.
3.
Devi, Sushma, et al.. (2025). Diosmin as Antidiabetic Agent: A Comprehensive Mechanistic Approach. Current Bioactive Compounds. 22(1). 1 indexed citations
4.
Rahamathulla, Mohamed, Sushma Devi, Manish Kumar, et al.. (2025). IRES activation: HK2 and TPI1 glycolytic enzymes play a pivotal role in non-neuronal cell survival under hypoxia. Artificial Cells Nanomedicine and Biotechnology. 53(1). 139–152. 1 indexed citations
5.
Arya, Preeti, et al.. (2025). Advanced Artificial Intelligence Technologies Transforming Contemporary Pharmaceutical Research. Bioengineering. 12(4). 363–363. 2 indexed citations
6.
Sudhaik, Anita, Rohit Kumar, Sushma Devi, et al.. (2024). Structural design of dual Z-scheme GCN/CdO/CaFe2O4 ternary heterojunction with high visible light activity: Photocatalytic performance and mechanism in the degradation of Congo red dye. Inorganic Chemistry Communications. 172. 113697–113697. 23 indexed citations
7.
Kciuk, Mateusz, Monika Saini, Somdutt Mujwar, et al.. (2024). Exploring the Comprehensive Neuroprotective and Anticancer Potential of Afzelin. Pharmaceuticals. 17(6). 701–701. 12 indexed citations
8.
9.
Devi, Sushma, et al.. (2024). Cross Talks between CNS and CVS Diseases: An Alliance to Annihilate. Current Cardiology Reviews. 20(3). 63–76.
10.
Kaur, Gagandeep, et al.. (2024). Free Fatty Acid Receptor Agonists for the Management of Type 2 Diabetes Mellitus. Pharmaceutical Chemistry Journal. 58(9). 1362–1369.
11.
Balaha, Mohamed, Sushma Devi, Ali Altharawi, et al.. (2023). Ameliorative Effects of Isoeugenol and Eugenol against Impaired Nerve Function and Inflammatory and Oxidative Mediators in Diabetic Neuropathic Rats. Biomedicines. 11(4). 1203–1203. 12 indexed citations
12.
Devi, Sushma, et al.. (2023). Recent Advances in Research and Management of Human Monkeypox Virus: An Emerging Global Health Threat. Viruses. 15(4). 937–937. 15 indexed citations
13.
Devi, Sushma, et al.. (2023). The Cardioprotective Effect of Corosolic Acid in the Diabetic Rats: A Possible Mechanism of the PPAR-γ Pathway. Molecules. 28(3). 929–929. 14 indexed citations
14.
Devi, Sushma, Mohammed F. Aldawsari, Ahmed I. Foudah, et al.. (2023). Effects of Tiliroside and Lisuride Co-Treatment on the PI3K/Akt Signal Pathway: Modulating Neuroinflammation and Apoptosis in Parkinson’s Disease. Biomedicines. 11(10). 2735–2735. 7 indexed citations
15.
Devi, Sushma, Samrat Chauhan, Ashi Mannan, & Thakur Gurjeet Singh. (2023). Targeting cardiovascular risk factors with eugenol: an anti-inflammatory perspective. Inflammopharmacology. 32(1). 307–317. 15 indexed citations
16.
Foudah, Ahmed I., Sushma Devi, Mohammed H. Alqarni, et al.. (2022). Quercetin Attenuates Nitroglycerin-Induced Migraine Headaches by Inhibiting Oxidative Stress and Inflammatory Mediators. Nutrients. 14(22). 4871–4871. 9 indexed citations
17.
Alqarni, Mohammed H., Sushma Devi, Akanksha Singh, et al.. (2022). Analgesic Action of Catechin on Chronic Constriction Injury–Induced Neuropathic Pain in Sprague–Dawley Rats. Frontiers in Pharmacology. 13. 895079–895079. 17 indexed citations
18.
Singh, Akanksha, Sushma Devi, Mohammad Sarwar Alam, et al.. (2021). Nanotechnology-based approaches applied to nutraceuticals. Drug Delivery and Translational Research. 12(3). 485–499. 45 indexed citations
19.
Zhu, Yunfeng, et al.. (2020). Evaluation of Gamma Amino Butyric Acid (GABA) and Glibenclamide Combination Therapy in Streptozotocin Induced Diabetes. Endocrine Metabolic & Immune Disorders - Drug Targets. 21(11). 2005–2016. 11 indexed citations
20.
Devi, Sushma & Randhir Singh. (2016). ANTIDIABETIC ACTIVITY OF METHANOLIC EXTRACT OF NEPETA HINDOSTANA HERB IN STREPTOZOTOCIN INDUCED DIABETES IN RATS. International Journal of Pharmacy and Pharmaceutical Sciences. 8(7). 330–335. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026